EUVIMEDEUVIMED entdecken
Crossref

Prognostic impact of peripheral artery disease in patients with and without high bleeding risk undergoing percutaneous coronary intervention

Alessandro Spirito iD, Rebecca Cohen iD, Samantha Sartori iD, Birgit Vogel, Usman Baber, Brunna Pileggi, Kenneth Smith, Danielle Nicosia, Karim Kamaleldin, Serdar Farhan iD, Annapoorna Kini iD, Samin K Sharma und 2 weitere

Catheterization and Cardiovascular Interventions · 2024

DOI: 10.1002/ccd.30960 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Catheterization and Cardiovascular Interventions, 2024. Verfasst von Alessandro Spirito und 13 weiteren Autor:innen. Beteiligte Einrichtung: The Zena and Michael A. Wiener Cardiovascular Institute, Icahn School of Medicine at Mount Sinai, New York, New York, USA. Hauptthemen laut MEDLINE: Coronary Artery Disease, Percutaneous Coronary Intervention, Drug-Eluting Stents, Peripheral Arterial Disease. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 24 Literaturangaben. Gefördert von: Zena and Michael A. Wiener Cardiovascular Institute Icahn School of Medicine at Mount Sinai.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Peripheral artery disease (PAD) is associated with worse outcomes after percutaneous coronary intervention (PCI). The aim of this study was to assess the prognostic impact of PAD according to high bleeding risk (HBR) status.

Methods

Consecutive patients undergoing PCI with drug‐eluting stent implantation at a tertiary‐care center (Mount Sinai Hospital) between 2012 and 2019 were stratified according to HBR and PAD status. The primary outcome was major adverse cardiac events (MACE), a composite of all‐cause death, myocardial infarction (MI), and stroke 1 year after PCI. Secondary outcomes included major bleeding.

Results

Out of 16,750 patients, 43% were HBR and 57% were no‐HBR. Within the two groups, PAD patients were 14% and 6%, respectively, and were more likely to have comorbidities and to undergo complex PCI than no‐PAD patients. Within the HBR group, PAD was associated with an increased risk of MACE (11.4% vs. 7.3%, hazard ratio [HR]: 1.59, 95% confidence interval [CI]: 1.27–1.99, p < 0.001) and a numerical nonsignificant increase of major bleeding (8.5% vs. 6.9%, HR: 1.25, 95% CI: 0.98–1.59, p = 0.066) as compared with no‐PAD. Among no‐HBR patients, rates of MACE and major bleeding were numerically but not significantly higher in the PAD group. After multivariable adjustment, PAD was no longer a predictor of adverse outcomes, irrespective of HBR status.

Conclusions

At 1‐year after PCI, PAD was associated with increased 1‐year risks of MACE in HBR patients. After adjustment for cardiovascular risk factors and comorbidities, the effect of PAD on adverse events was largely attenuated.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Coronary Artery DiseasePercutaneous Coronary InterventionDrug-Eluting StentsPeripheral Arterial DiseaseHumansPrognosisTreatment OutcomeHemorrhagePlatelet Aggregation InhibitorsRisk Factors

Stichwörter der Autor:innen

bleedinghigh bleeding riskoutcomespercutaneous coronary interventionperipheral artery disease

Substanzen

Platelet Aggregation Inhibitors

Autor:innen und Institutionen

  • The Zena and Michael A. Wiener Cardiovascular Institute, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
  • Department of Cardiology, The University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA.
  • Department of Cardiopneumonology, Heart Institute of the University of Sao Paulo, Sao Paulo, Brazil.

ORCID-Profile: Alessandro Spirito, Rebecca Cohen, Samantha Sartori, Serdar Farhan, Annapoorna Kini, George Dangas, Roxana Mehran

Förderung

  • Zena and Michael A. Wiener Cardiovascular Institute Icahn School of Medicine at Mount Sinai

Zitieren

APA

Spirito, A., Cohen, R., Sartori, S., Vogel, B., Baber, U., Pileggi, B., Smith, K., Nicosia, D., Kamaleldin, K., Farhan, S., Kini, A., Sharma, S. K., Dangas, G., & Mehran, R. (2024). Prognostic impact of peripheral artery disease in patients with and without high bleeding risk undergoing percutaneous coronary intervention. Catheterization and Cardiovascular Interventions. https://doi.org/10.1002/ccd.30960

Vancouver

Spirito A, Cohen R, Sartori S, Vogel B, Baber U, Pileggi B, et al. Prognostic impact of peripheral artery disease in patients with and without high bleeding risk undergoing percutaneous coronary intervention. Catheterization and Cardiovascular Interventions. 2024. doi:10.1002/ccd.30960

BibTeX
@article{Spirito2024,
  author = {Spirito, Alessandro and Cohen, Rebecca and Sartori, Samantha and Vogel, Birgit and Baber, Usman and Pileggi, Brunna and Smith, Kenneth and Nicosia, Danielle and Kamaleldin, Karim and Farhan, Serdar and Kini, Annapoorna and Sharma, Samin K and Dangas, George and Mehran, Roxana},
  title = {Prognostic impact of peripheral artery disease in patients with and without high bleeding risk undergoing percutaneous coronary intervention},
  journal = {Catheterization and Cardiovascular Interventions},
  year = {2024},
  doi = {10.1002/ccd.30960}
}
Kostenlos starten →